『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:

登録内容 (EID=322683)

EID=322683EID:322683, Map:0, LastModified:2017年3月4日(土) 19:19:49, Operator:[大家 隆弘], Avail:TRUE, Censor:0, Owner:[松久 宗英], Read:継承, Write:継承, Delete:継承.
種別 (必須): 学術論文 (審査論文) [継承]
言語 (必須): 英語 [継承]
招待 (推奨):
審査 (推奨):
カテゴリ (推奨):
共著種別 (推奨):
学究種別 (推奨):
組織 (推奨):
著者 (必須): 1. (英) King Allen B (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
2.黒田 暁生 ([徳島大学.先端酵素学研究所.基幹研究部門])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
3.松久 宗英 ([徳島大学.先端酵素学研究所.基幹研究部門]/徳島大学病院アンチエイジングセンター センター長(併任))
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
4. (英) Hobbs Todd (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
題名 (必須): (英) A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.  (日)    [継承]
副題 (任意):
要約 (任意): (英)   (日) Dosing guidelines for patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII), which are historically based on clinical experience and retrospective studies of patients consuming an American diet, recommend that basal insulin should represent approximately 50 % of the total daily dose (TDD). Recent prospective studies in the USA and Japan conclude that the more appropriate proportion is closer to 30-40 % of TDD. In addition, currently used formulas for calculating the carbohydrate-to-insulin ratio (CIR) and correction factor (CF) may lead to underdosing of bolus insulin by as much as 12.8-50 % for a hypothetical patient. The discrepancies between traditional formulas and data from newer studies can be accounted for by the more rigorous design of the newer studies (e.g., prospective design, controlled diets, meal omission, and frequent glucose monitoring). International differences in diet composition may also be important to consider when developing dosing recommendations for CSII.   [継承]
キーワード (推奨):
発行所 (推奨):
誌名 (必須): Current Diabetes Reports (Springer US)
(pISSN: 1534-4827, eISSN: 1539-0829)

ISSN (任意): 1539-0829
ISSN: 1534-4827 (pISSN: 1534-4827, eISSN: 1539-0829)
Title: Current diabetes reports
Title(ISO): Curr Diab Rep
Publisher: Current Medicine Group LLC
 (NLM Catalog  (Scopus  (CrossRef (Scopus information is found. [need login])
[継承]
[継承]
(必須): 16 [継承]
(必須): 9 [継承]
(必須):
都市 (任意):
年月日 (必須): 西暦 2016年 9月 初日 (平成 28年 9月 初日) [継承]
URL (任意):
DOI (任意): 10.1007/s11892-016-0772-0    (→Scopusで検索) [継承]
PMID (任意): 27457238    (→Scopusで検索) [継承]
NAID (任意):
WOS (任意):
Scopus (任意):
評価値 (任意):
被引用数 (任意):
指導教員 (推奨):
備考 (任意): 1.(英) PublicationType: Journal Article  (日)    [継承]
2.(英) PublicationType: Review  (日)    [継承]

標準的な表示

和文冊子 ● B Allen King, Akio Kuroda, Munehide Matsuhisa and Todd Hobbs : A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes., Current Diabetes Reports, Vol.16, No.9, (頁), 2016.
欧文冊子 ● B Allen King, Akio Kuroda, Munehide Matsuhisa and Todd Hobbs : A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes., Current Diabetes Reports, Vol.16, No.9, (頁), 2016.

関連情報

Number of session users = 1, LA = 0.49, Max(EID) = 373420, Max(EOID) = 999309.